{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T15:53:05Z","timestamp":1783698785188,"version":"3.55.0"},"reference-count":61,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2024,4,22]],"date-time":"2024-04-22T00:00:00Z","timestamp":1713744000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,4,22]],"date-time":"2024-04-22T00:00:00Z","timestamp":1713744000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Center of geriatric coronary artery disease, Huadong Hospital Affiliated to Fudan University","award":["LCZX2205"],"award-info":[{"award-number":["LCZX2205"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Endocrine"],"DOI":"10.1007\/s12020-024-03823-2","type":"journal-article","created":{"date-parts":[[2024,4,22]],"date-time":"2024-04-22T10:01:57Z","timestamp":1713780117000},"page":"969-979","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Semaglutide attenuates pathological electrophysiological remodeling in diabetic cardiomyopathy via restoring Cx43 expression"],"prefix":"10.1007","volume":"84","author":[{"given":"Meiling","family":"Yan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaibin","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingbo","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinkai","family":"Qu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kankai","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,4,22]]},"reference":[{"key":"3823_CR1","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2019.107843","volume":"157","author":"P Saeedi","year":"2019","unstructured":"P. Saeedi, I. Petersohn, P. Salpea, B. Malanda, S. Karuranga, N. Unwin, S. Colagiuri, L. Guariguata, A.A. Motala, K. Ogurtsova, J.E. Shaw, D. Bright, R. Williams, Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: results from the International Diabetes Federation Diabetes Atlas, 9(th) edition. Diabetes Res. Clin. Pract. 157, 107843 (2019). https:\/\/doi.org\/10.1016\/j.diabres.2019.107843","journal-title":"Diabetes Res. Clin. Pract."},{"issue":"1","key":"3823_CR2","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/0002-9149(74)90089-7","volume":"34","author":"WB Kannel","year":"1974","unstructured":"W.B. Kannel, M. Hjortland, W.P. Castelli, Role of diabetes in congestive heart failure: the Framingham study. Am. J. Cardiol. 34(1), 29\u201334 (1974). https:\/\/doi.org\/10.1016\/0002-9149(74)90089-7","journal-title":"Am. J. Cardiol."},{"issue":"8","key":"3823_CR3","doi-asserted-by":"publisher","first-page":"1160","DOI":"10.1161\/circresaha.118.314665","volume":"124","author":"WH Dillmann","year":"2019","unstructured":"W.H. Dillmann, Diabetic cardiomyopathy. Circ. Res 124(8), 1160\u20131162 (2019). https:\/\/doi.org\/10.1161\/circresaha.118.314665","journal-title":"Circ. Res"},{"issue":"11","key":"3823_CR4","doi-asserted-by":"publisher","first-page":"1501","DOI":"10.1161\/circresaha.120.315913","volume":"126","author":"RH Ritchie","year":"2020","unstructured":"R.H. Ritchie, E.D. Abel, Basic mechanisms of diabetic heart disease. Circ. Res. 126(11), 1501\u20131525 (2020). https:\/\/doi.org\/10.1161\/circresaha.120.315913","journal-title":"Circ. Res."},{"key":"3823_CR5","doi-asserted-by":"publisher","first-page":"1514","DOI":"10.3389\/fphys.2018.01514","volume":"9","author":"G Borghetti","year":"2018","unstructured":"G. Borghetti, D. von Lewinski, D.M. Eaton, H. Sourij, S.R. Houser, M. Wallner, Diabetic cardiomyopathy: current and future therapies. beyond glycemic control. Front. Physiol. 9, 1514 (2018). https:\/\/doi.org\/10.3389\/fphys.2018.01514","journal-title":"Front. Physiol."},{"issue":"9","key":"3823_CR6","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1038\/s41569-020-0339-2","volume":"17","author":"Y Tan","year":"2020","unstructured":"Y. Tan, Z. Zhang, C. Zheng, K.A. Wintergerst, B.B. Keller, L. Cai, Mechanisms of diabetic cardiomyopathy and potential therapeutic strategies: preclinical and clinical evidence. Nat. Rev. Cardiol. 17(9), 585\u2013607 (2020). https:\/\/doi.org\/10.1038\/s41569-020-0339-2","journal-title":"Nat. Rev. Cardiol."},{"issue":"3","key":"3823_CR7","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1016\/j.hfc.2019.02.003","volume":"15","author":"S Paolillo","year":"2019","unstructured":"S. Paolillo, F. Marsico, M. Prastaro, F. Renga, L. Esposito, F. De Martino, P. Di Napoli, I. Esposito, A. Ambrosio, M. Ianniruberto, R. Mennella, R. Paolillo, P. Gargiulo, Diabetic cardiomyopathy: definition, diagnosis, and therapeutic implications. Heart Fail. Clin. 15(3), 341\u2013347 (2019). https:\/\/doi.org\/10.1016\/j.hfc.2019.02.003","journal-title":"Heart Fail. Clin."},{"issue":"6","key":"3823_CR8","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1111\/jdi.12250","volume":"5","author":"Q Liu","year":"2014","unstructured":"Q. Liu, S. Wang, L. Cai, Diabetic cardiomyopathy and its mechanisms: role of oxidative stress and damage. J. Diabetes Investig. 5(6), 623\u2013634 (2014). https:\/\/doi.org\/10.1111\/jdi.12250","journal-title":"J. Diabetes Investig."},{"key":"3823_CR9","doi-asserted-by":"publisher","unstructured":"V.U. Nna, A.B. Abu Bakar, A. Ahmad, C.O. Eleazu, M. Mohamed, Oxidative stress, NF-\u03baB-mediated inflammation and apoptosis in the testes of streptozotocin-induced diabetic rats: combined protective effects of Malaysian propolis and metformin. Antioxidants 8(10), (2019). https:\/\/doi.org\/10.3390\/antiox8100465","DOI":"10.3390\/antiox8100465"},{"issue":"1","key":"3823_CR10","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1007\/s11154-010-9131-7","volume":"11","author":"S Boudina","year":"2010","unstructured":"S. Boudina, E.D. Abel, Diabetic cardiomyopathy, causes and effects. Rev. Endocr. Metab. Disord. 11(1), 31\u201339 (2010). https:\/\/doi.org\/10.1007\/s11154-010-9131-7","journal-title":"Rev. Endocr. Metab. Disord."},{"issue":"3","key":"3823_CR11","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/j.tips.2010.12.001","volume":"32","author":"MJ Cutler","year":"2011","unstructured":"M.J. Cutler, D. Jeyaraj, D.S. Rosenbaum, Cardiac electrical remodeling in health and disease. Trends Pharmacol. Sci. 32(3), 174\u2013180 (2011). https:\/\/doi.org\/10.1016\/j.tips.2010.12.001","journal-title":"Trends Pharmacol. Sci."},{"issue":"2","key":"3823_CR12","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1038\/s42255-020-00327-x","volume":"3","author":"FM Gribble","year":"2021","unstructured":"F.M. Gribble, F. Reimann, Metabolic messengers: glucagon-like peptide 1. Nat. Metab. 3(2), 142\u2013148 (2021). https:\/\/doi.org\/10.1038\/s42255-020-00327-x","journal-title":"Nat. Metab."},{"key":"3823_CR13","doi-asserted-by":"publisher","unstructured":"S. Pandey, S. Mangmool, W. Parichatikanond, Multifaceted roles of GLP-1 and its analogs: a review on molecular mechanisms with a cardiotherapeutic perspective. Pharmaceuticals 16(6), (2023). https:\/\/doi.org\/10.3390\/ph16060836","DOI":"10.3390\/ph16060836"},{"key":"3823_CR14","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2020.603247","volume":"11","author":"K Gopal","year":"2020","unstructured":"K. Gopal, J.J. Chahade, R. Kim, J.R. Ussher, The impact of antidiabetic therapies on diastolic dysfunction and diabetic cardiomyopathy. Front. Physiol. 11, 603247 (2020). https:\/\/doi.org\/10.3389\/fphys.2020.603247","journal-title":"Front. Physiol."},{"key":"3823_CR15","doi-asserted-by":"publisher","first-page":"178","DOI":"10.3389\/fendo.2020.00178","volume":"11","author":"MP Gilbert","year":"2020","unstructured":"M.P. Gilbert, R.E. Pratley, GLP-1 analogs and DPP-4 inhibitors in type 2 diabetes therapy: review of head-to-head clinical trials. Front. Endocrinol. 11, 178 (2020). https:\/\/doi.org\/10.3389\/fendo.2020.00178","journal-title":"Front. Endocrinol."},{"key":"3823_CR16","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2020.118645","volume":"264","author":"H Yaribeygi","year":"2021","unstructured":"H. Yaribeygi, A. Rashidy-Pour, S.L. Atkin, T. Jamialahmadi, A. Sahebkar, GLP-1 mimetics and cognition. Life Sci. 264, 118645 (2021). https:\/\/doi.org\/10.1016\/j.lfs.2020.118645","journal-title":"Life Sci."},{"issue":"8","key":"3823_CR17","doi-asserted-by":"publisher","first-page":"2050","DOI":"10.7150\/ijbs.59965","volume":"17","author":"X Ma","year":"2021","unstructured":"X. Ma, Z. Liu, I. Ilyas, P.J. Little, D. Kamato, A. Sahebka, Z. Chen, S. Luo, X. Zheng, J. Weng, S. Xu, GLP-1 receptor agonists (GLP-1RAs): cardiovascular actions and therapeutic potential. Int. J. Biol. Sci. 17(8), 2050\u20132068 (2021). https:\/\/doi.org\/10.7150\/ijbs.59965","journal-title":"Int. J. Biol. Sci."},{"issue":"6","key":"3823_CR18","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/j.hjc.2018.11.008","volume":"60","author":"E Andrikou","year":"2019","unstructured":"E. Andrikou, C. Tsioufis, I. Andrikou, I. Leontsinis, D. Tousoulis, N. Papanas, GLP-1 receptor agonists and cardiovascular outcome trials: An update. Hell. J. Cardiol. (Hellenike Kardiologike Epitheorese) 60(6), 347\u2013351 (2019). https:\/\/doi.org\/10.1016\/j.hjc.2018.11.008","journal-title":"Hell. J. Cardiol. (Hellenike Kardiologike Epitheorese)"},{"issue":"7","key":"3823_CR19","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1038\/s41569-023-00849-3","volume":"20","author":"JR Ussher","year":"2023","unstructured":"J.R. Ussher, D.J. Drucker, Glucagon-like peptide 1 receptor agonists: cardiovascular benefits and mechanisms of action. Nat. Rev. Cardiol. 20(7), 463\u2013474 (2023). https:\/\/doi.org\/10.1038\/s41569-023-00849-3","journal-title":"Nat. Rev. Cardiol."},{"issue":"11","key":"3823_CR20","doi-asserted-by":"publisher","DOI":"10.1007\/s11886-018-1051-2","volume":"20","author":"Y Li","year":"2018","unstructured":"Y. Li, P.D. Rosenblit, Glucagon-like peptide-1 receptor agonists and cardiovascular risk reduction in type 2 diabetes mellitus: is it a class effect? Curr. Cardiol. Rep. 20(11), 113 (2018). https:\/\/doi.org\/10.1007\/s11886-018-1051-2","journal-title":"Curr. Cardiol. Rep."},{"issue":"4","key":"3823_CR21","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1210\/me.2014-1346","volume":"29","author":"S Mangmool","year":"2015","unstructured":"S. Mangmool, P. Hemplueksa, W. Parichatikanond, N. Chattipakorn, Epac is required for GLP-1R-mediated inhibition of oxidative stress and apoptosis in cardiomyocytes. Mol. Endocrinol. 29(4), 583\u2013596 (2015). https:\/\/doi.org\/10.1210\/me.2014-1346","journal-title":"Mol. Endocrinol."},{"issue":"12","key":"3823_CR22","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1055\/a-1162-8196","volume":"129","author":"NM Ramadan","year":"2021","unstructured":"N.M. Ramadan, H.A. Malek, K.A. Rahman, E. El-Kholy, D. Shaalan, W. Elkashef, Liraglutide effect on ventricular transient outward K+ channel and connexin-43 protein expression. Exp. Clin. Endocrinol. Diabetes 129(12), 899\u2013907 (2021). https:\/\/doi.org\/10.1055\/a-1162-8196","journal-title":"Exp. Clin. Endocrinol. Diabetes"},{"issue":"19","key":"3823_CR23","doi-asserted-by":"publisher","first-page":"1834","DOI":"10.1056\/NEJMoa1607141","volume":"375","author":"SP Marso","year":"2016","unstructured":"S.P. Marso, S.C. Bain, A. Consoli, F.G. Eliaschewitz, E. J\u00f3dar, L.A. Leiter, I. Lingvay, J. Rosenstock, J. Seufert, M.L. Warren, V. Woo, O. Hansen, A.G. Holst, J. Pettersson, T. Vilsb\u00f8ll, Semaglutide and cardiovascular outcomes in patients with type 2 diabetes. N. Engl. J. Med. 375(19), 1834\u20131844 (2016). https:\/\/doi.org\/10.1056\/NEJMoa1607141","journal-title":"N. Engl. J. Med."},{"issue":"9","key":"3823_CR24","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1056\/NEJMoa1901118","volume":"381","author":"M Husain","year":"2019","unstructured":"M. Husain, A.L. Birkenfeld, M. Donsmark, K. Dungan, F.G. Eliaschewitz, D.R. Franco, O.K. Jeppesen, I. Lingvay, O. Mosenzon, S.D. Pedersen, C.J. Tack, M. Thomsen, T. Vilsb\u00f8ll, M.L. Warren, S.C. Bain, Oral semaglutide and cardiovascular outcomes in patients with type 2 diabetes. N. Engl. J. Med. 381(9), 841\u2013851 (2019). https:\/\/doi.org\/10.1056\/NEJMoa1901118","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"3823_CR25","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1007\/s13340-015-0212-4","volume":"7","author":"K Sakaguchi","year":"2016","unstructured":"K. Sakaguchi, K. Takeda, M. Maeda, W. Ogawa, T. Sato, S. Okada, Y. Ohnishi, H. Nakajima, A. Kashiwagi, Glucose area under the curve during oral glucose tolerance test as an index of glucose intolerance. Diabetol. Int. 7(1), 53\u201358 (2016). https:\/\/doi.org\/10.1007\/s13340-015-0212-4","journal-title":"Diabetol. Int."},{"issue":"3","key":"3823_CR26","doi-asserted-by":"publisher","first-page":"H747","DOI":"10.1152\/ajpheart.1998.274.3.H747","volume":"274","author":"GF Mitchell","year":"1998","unstructured":"G.F. Mitchell, A. Jeron, G. Koren, Measurement of heart rate and Q-T interval in the conscious mouse. Am. J. Physiol. 274(3), H747\u2013H751 (1998). https:\/\/doi.org\/10.1152\/ajpheart.1998.274.3.H747","journal-title":"Am. J. Physiol."},{"issue":"3","key":"3823_CR27","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1093\/abbs\/gmy177","volume":"51","author":"T Zhao","year":"2019","unstructured":"T. Zhao, H. Chen, F. Xu, J. Wang, Y. Liu, X. Xing, L. Guo, M. Zhang, Q. Lu, Liraglutide alleviates cardiac fibrosis through inhibiting P4h\u03b1-1 expression in STZ-induced diabetic cardiomyopathy. Acta Biochim. Biophys. Sin. 51(3), 293\u2013300 (2019). https:\/\/doi.org\/10.1093\/abbs\/gmy177","journal-title":"Acta Biochim. Biophys. Sin."},{"issue":"2","key":"3823_CR28","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1007\/s00395-015-0476-7","volume":"110","author":"E Robinson","year":"2015","unstructured":"E. Robinson, R.S. Cassidy, M. Tate, Y. Zhao, S. Lockhart, D. Calderwood, R. Church, M.K. McGahon, D.P. Brazil, B.J. McDermott, B.D. Green, D.J. Grieve, Exendin-4 protects against post-myocardial infarction remodelling via specific actions on inflammation and the extracellular matrix. Basic Res. Cardiol. 110(2), 20 (2015). https:\/\/doi.org\/10.1007\/s00395-015-0476-7","journal-title":"Basic Res. Cardiol."},{"key":"3823_CR29","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2022.106320","volume":"182","author":"G Bendotti","year":"2022","unstructured":"G. Bendotti, L. Montefusco, M.E. Lunati, V. Usuelli, I. Pastore, E. Lazzaroni, E. Assi, A.J. Seelam, B. El Essawy, J. Jang, C. Loretelli, F. D\u2019Addio, C. Berra, M. Ben Nasr, G. Zuccotti, P. Fiorina, The anti-inflammatory and immunological properties of GLP-1 receptor agonists. Pharm. Res. 182, 106320 (2022). https:\/\/doi.org\/10.1016\/j.phrs.2022.106320","journal-title":"Pharm. Res."},{"issue":"1","key":"3823_CR30","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1186\/s12933-022-01486-9","volume":"21","author":"A Sforza","year":"2022","unstructured":"A. Sforza, V. Vigorelli, E. Rurali, G.L. Perrucci, E. Gambini, M. Arici, A. Metallo, R. Rinaldi, P. Fiorina, A. Barbuti, A. Raucci, E. Sacco, M. Rocchetti, G. Pompilio, S. Genovese, M.C. Vinci, Liraglutide preserves CD34+ stem cells from dysfunction Induced by high glucose exposure. Cardiovasc. Diabetol. 21(1), 51 (2022). https:\/\/doi.org\/10.1186\/s12933-022-01486-9","journal-title":"Cardiovasc. Diabetol."},{"issue":"9","key":"3823_CR31","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1016\/j.cardfail.2006.08.211","volume":"12","author":"GG Sokos","year":"2006","unstructured":"G.G. Sokos, L.A. Nikolaidis, S. Mankad, D. Elahi, R.P. Shannon, Glucagon-like peptide-1 infusion improves left ventricular ejection fraction and functional status in patients with chronic heart failure. J. Card. Fail. 12(9), 694\u2013699 (2006). https:\/\/doi.org\/10.1016\/j.cardfail.2006.08.211","journal-title":"J. Card. Fail."},{"key":"3823_CR32","doi-asserted-by":"publisher","unstructured":"B. De Geest, M. Mishra, Role of oxidative stress in diabetic cardiomyopathy. Antioxidants 11(4), (2022). https:\/\/doi.org\/10.3390\/antiox11040784","DOI":"10.3390\/antiox11040784"},{"key":"3823_CR33","doi-asserted-by":"publisher","first-page":"202","DOI":"10.3389\/fendo.2019.00202","volume":"10","author":"W Ding","year":"2019","unstructured":"W. Ding, W.G. Chang, X.C. Guo, Y. Liu, D.D. Xiao, D. Ding, J.X. Wang, X.J. Zhang, Exenatide protects against cardiac dysfunction by attenuating oxidative stress in the diabetic mouse heart. Front. Endocrinol. 10, 202 (2019). https:\/\/doi.org\/10.3389\/fendo.2019.00202","journal-title":"Front. Endocrinol."},{"key":"3823_CR34","doi-asserted-by":"publisher","unstructured":"A. Winiarska, M. Knysak, K. Nabrdalik, J. Gumprecht, T. Stomp\u00f3r, Inflammation and oxidative stress in diabetic kidney disease: the targets for SGLT2 inhibitors and GLP-1 receptor agonists. Int. J. Mol. Sci. 22(19), (2021). https:\/\/doi.org\/10.3390\/ijms221910822","DOI":"10.3390\/ijms221910822"},{"issue":"9002","key":"3823_CR35","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1016\/S0140-6736(96)91246-5","volume":"347","author":"P Fiorina","year":"1996","unstructured":"P. Fiorina, G. Lattuada, O. Ponari, C. Silvestrini, P. DallAglio, Impaired nocturnal melatonin excretion and changes of immunological status in ischaemic stroke patients. Lancet 347(9002), 692\u2013693 (1996)","journal-title":"Lancet"},{"issue":"3","key":"3823_CR36","doi-asserted-by":"publisher","first-page":"H295","DOI":"10.1152\/ajpheart.00990.2012","volume":"305","author":"A Monji","year":"2013","unstructured":"A. Monji, T. Mitsui, Y.K. Bando, M. Aoyama, T. Shigeta, T. Murohara, Glucagon-like peptide-1 receptor activation reverses cardiac remodeling via normalizing cardiac steatosis and oxidative stress in type 2 diabetes. Am. J. Physiol. Heart Circ. Physiol. 305(3), H295\u2013H304 (2013). https:\/\/doi.org\/10.1152\/ajpheart.00990.2012","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"issue":"2","key":"3823_CR37","doi-asserted-by":"publisher","first-page":"3251","DOI":"10.1080\/21655979.2021.2022270","volume":"13","author":"Y Liu","year":"2022","unstructured":"Y. Liu, L. Chen, H. Wu, H. Zhang, Protective effect of glucagon-like peptide-1 mediated by ultrasound microbubbles on myocardial injury in rats with diabetic cardiomyopathy. Bioengineered 13(2), 3251\u20133261 (2022). https:\/\/doi.org\/10.1080\/21655979.2021.2022270","journal-title":"Bioengineered"},{"issue":"5 Pt B","key":"3823_CR38","doi-asserted-by":"publisher","first-page":"1908","DOI":"10.1016\/j.bbadis.2017.07.025","volume":"1864","author":"SS Hansen","year":"2018","unstructured":"S.S. Hansen, E. Aasum, A.D. Hafstad, The role of NADPH oxidases in diabetic cardiomyopathy. Biochim. Biophys. Acta Mol. Basis Dis. 1864(5 Pt B), 1908\u20131913 (2018). https:\/\/doi.org\/10.1016\/j.bbadis.2017.07.025","journal-title":"Biochim. Biophys. Acta Mol. Basis Dis."},{"issue":"12","key":"3823_CR39","doi-asserted-by":"publisher","first-page":"1484","DOI":"10.1007\/s10495-009-0352-8","volume":"14","author":"CM Kusminski","year":"2009","unstructured":"C.M. Kusminski, S. Shetty, L. Orci, R.H. Unger, P.E. Scherer, Diabetes and apoptosis: lipotoxicity. Apoptosis 14(12), 1484\u20131495 (2009). https:\/\/doi.org\/10.1007\/s10495-009-0352-8","journal-title":"Apoptosis"},{"issue":"4","key":"3823_CR40","doi-asserted-by":"publisher","DOI":"10.1111\/acel.12763","volume":"17","author":"L Wu","year":"2018","unstructured":"L. Wu, K. Wang, W. Wang, Z. Wen, P. Wang, L. Liu, D.W. Wang, Glucagon-like peptide-1 ameliorates cardiac lipotoxicity in diabetic cardiomyopathy via the PPAR\u03b1 pathway. Aging Cell 17(4), e12763 (2018). https:\/\/doi.org\/10.1111\/acel.12763","journal-title":"Aging Cell"},{"issue":"4","key":"3823_CR41","doi-asserted-by":"publisher","first-page":"H1361","DOI":"10.1152\/ajpheart.00885.2010","volume":"300","author":"S Ravassa","year":"2011","unstructured":"S. Ravassa, A. Zudaire, R.D. Carr, J. D\u00edez, Antiapoptotic effects of GLP-1 in murine HL-1 cardiomyocytes. Am. J. Physiol. Heart Circ. Physiol. 300(4), H1361\u2013H1372 (2011). https:\/\/doi.org\/10.1152\/ajpheart.00885.2010","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"issue":"2","key":"3823_CR42","doi-asserted-by":"publisher","first-page":"1593","DOI":"10.3892\/mmr.2015.4724","volume":"13","author":"H Zhang","year":"2016","unstructured":"H. Zhang, Z. Xiong, J. Wang, S. Zhang, L. Lei, L. Yang, Z. Zhang, Glucagon-like peptide-1 protects cardiomyocytes from advanced oxidation protein product-induced apoptosis via the PI3K\/Akt\/Bad signaling pathway. Mol. Med. Rep. 13(2), 1593\u20131601 (2016). https:\/\/doi.org\/10.3892\/mmr.2015.4724","journal-title":"Mol. Med. Rep."},{"key":"3823_CR43","doi-asserted-by":"publisher","unstructured":"N.N. Trang, C.C. Chung, T.W. Lee, W.L. Cheng, Y.H. Kao, S.Y. Huang, T.I. Lee, Y.J. Chen, Empagliflozin and liraglutide differentially modulate cardiac metabolism in diabetic cardiomyopathy in rats. Int. J. Mol. Sci. 22(3), (2021). https:\/\/doi.org\/10.3390\/ijms22031177","DOI":"10.3390\/ijms22031177"},{"key":"3823_CR44","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.bbrc.2023.01.049","volume":"647","author":"Q Zhu","year":"2023","unstructured":"Q. Zhu, Y. Luo, Y. Wen, D. Wang, J. Li, Z. Fan, Semaglutide inhibits ischemia\/reperfusion-induced cardiomyocyte apoptosis through activating PKG\/PKC\u03b5\/ERK1\/2 pathway. Biochem. Biophys. Res. Commun. 647, 1\u20138 (2023). https:\/\/doi.org\/10.1016\/j.bbrc.2023.01.049","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"3823_CR45","doi-asserted-by":"publisher","first-page":"598012","DOI":"10.3389\/fendo.2020.598012","volume":"11","author":"AJ Wang","year":"2020","unstructured":"A.J. Wang, S. Wang, B.J. Wang, M. Xiao, Y. Guo, Y. Tang, J. Zhang, J. Gu, Epigenetic regulation associated with sirtuin 1 in complications of diabetes mellitus. Front. Endocrinol. 11, 598012 (2020). https:\/\/doi.org\/10.3389\/fendo.2020.598012","journal-title":"Front. Endocrinol."},{"issue":"2","key":"3823_CR46","doi-asserted-by":"publisher","first-page":"484","DOI":"10.7150\/ijbs.78654","volume":"19","author":"C Lu","year":"2023","unstructured":"C. Lu, H. Zhao, Y. Liu, Z. Yang, H. Yao, T. Liu, T. Gou, L. Wang, J. Zhang, Y. Tian, Y. Yang, H. Zhang, Novel role of the SIRT1 in endocrine and metabolic diseases. Int. J. Biol. Sci. 19(2), 484\u2013501 (2023). https:\/\/doi.org\/10.7150\/ijbs.78654","journal-title":"Int. J. Biol. Sci."},{"issue":"5","key":"3823_CR47","doi-asserted-by":"publisher","DOI":"10.1002\/jbt.23330","volume":"37","author":"S Seksaria","year":"2023","unstructured":"S. Seksaria, S. Mehan, B.J. Dutta, G.D. Gupta, S.S. Ganti, A. Singh, Oxymatrine and insulin resistance: focusing on mechanistic intricacies involve in diabetes associated cardiomyopathy via SIRT1\/AMPK and TGF-\u03b2 signaling pathway. J. Biochem. Mol. Toxicol. 37(5), e23330 (2023). https:\/\/doi.org\/10.1002\/jbt.23330","journal-title":"J. Biochem. Mol. Toxicol."},{"key":"3823_CR48","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2021.634900","volume":"9","author":"W Jia","year":"2021","unstructured":"W. Jia, T. Bai, J. Zeng, Z. Niu, D. Fan, X. Xu, M. Luo, P. Wang, Q. Zou, X. Dai, Combined administration of metformin and atorvastatin attenuates diabetic cardiomyopathy by inhibiting inflammation, apoptosis, and oxidative stress in type 2 diabetic mice. Front. Cell Dev. Biol. 9, 634900 (2021). https:\/\/doi.org\/10.3389\/fcell.2021.634900","journal-title":"Front. Cell Dev. Biol."},{"issue":"1","key":"3823_CR49","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1016\/j.atherosclerosis.2015.03.026","volume":"240","author":"T Inoue","year":"2015","unstructured":"T. Inoue, T. Inoguchi, N. Sonoda, H. Hendarto, H. Makimura, S. Sasaki, H. Yokomizo, Y. Fujimura, D. Miura, R. Takayanagi, GLP-1 analog liraglutide protects against cardiac steatosis, oxidative stress and apoptosis in streptozotocin-induced diabetic rats. Atherosclerosis 240(1), 250\u2013259 (2015). https:\/\/doi.org\/10.1016\/j.atherosclerosis.2015.03.026","journal-title":"Atherosclerosis"},{"key":"3823_CR50","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.yjmcc.2021.01.006","volume":"155","author":"M Rattka","year":"2021","unstructured":"M. Rattka, S. Westphal, B.M. Gahr, S. Just, W. Rottbauer, Spen deficiency interferes with Connexin 43 expression and leads to heart failure in zebrafish. J. Mol. Cell Cardiol. 155, 25\u201335 (2021). https:\/\/doi.org\/10.1016\/j.yjmcc.2021.01.006","journal-title":"J. Mol. Cell Cardiol."},{"key":"3823_CR51","doi-asserted-by":"publisher","unstructured":"A. Rodr\u00edguez-Sinovas, J.A. S\u00e1nchez, L. Valls-Lacalle, M. Consegal, I. Ferreira-Gonz\u00e1lez, Connexins in the heart: regulation, function and involvement in cardiac disease. Int. J. Mol. Sci. 22(9) (2021). https:\/\/doi.org\/10.3390\/ijms22094413","DOI":"10.3390\/ijms22094413"},{"issue":"2","key":"3823_CR52","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1111\/1753-0407.12164","volume":"7","author":"MS Joshi","year":"2015","unstructured":"M.S. Joshi, M.J. Mihm, A.C. Cook, B.L. Schanbacher, J.A. Bauer, Alterations in connexin 43 during diabetic cardiomyopathy: competition of tyrosine nitration versus phosphorylation. J. Diabetes 7(2), 250\u2013259 (2015). https:\/\/doi.org\/10.1111\/1753-0407.12164","journal-title":"J. Diabetes"},{"issue":"1\u20132","key":"3823_CR53","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1007\/s11010-006-9166-y","volume":"290","author":"H Lin","year":"2006","unstructured":"H. Lin, K. Ogawa, I. Imanaga, N. Tribulova, Remodeling of connexin 43 in the diabetic rat heart. Mol. Cell. Biochem. 290(1\u20132), 69\u201378 (2006). https:\/\/doi.org\/10.1007\/s11010-006-9166-y","journal-title":"Mol. Cell. Biochem."},{"key":"3823_CR54","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.yjmcc.2016.01.023","volume":"92","author":"S Veeranki","year":"2016","unstructured":"S. Veeranki, S. Givvimani, S. Kundu, N. Metreveli, S. Pushpakumar, S.C. Tyagi, Moderate intensity exercise prevents diabetic cardiomyopathy associated contractile dysfunction through restoration of mitochondrial function and connexin 43 levels in db\/db mice. J. Mol. Cell Cardiol. 92, 163\u2013173 (2016). https:\/\/doi.org\/10.1016\/j.yjmcc.2016.01.023","journal-title":"J. Mol. Cell Cardiol."},{"issue":"1-2","key":"3823_CR55","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1007\/s11010-007-9537-z","volume":"305","author":"FC Howarth","year":"2007","unstructured":"F.C. Howarth, N. Nowotny, E. Zilahi, M.A. El Haj, M. Lei, Altered expression of gap junction connexin proteins may partly underlie heart rhythm disturbances in the streptozotocin-induced diabetic rat heart. Mol. Cell. Biochem. 305(1-2), 145\u2013151 (2007). https:\/\/doi.org\/10.1007\/s11010-007-9537-z","journal-title":"Mol. Cell. Biochem."},{"issue":"4","key":"3823_CR56","doi-asserted-by":"publisher","first-page":"H1762","DOI":"10.1152\/ajpheart.00346.2004","volume":"287","author":"S Poelzing","year":"2004","unstructured":"S. Poelzing, D.S. Rosenbaum, Altered connexin43 expression produces arrhythmia substrate in heart failure. Am. J. Physiol. Heart Circ. Physiol. 287(4), H1762\u2013H1770 (2004)","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"issue":"10","key":"3823_CR57","doi-asserted-by":"publisher","first-page":"1194","DOI":"10.1161\/hc3601.093990","volume":"104","author":"DE Gutstein","year":"2001","unstructured":"D.E. Gutstein, G.E. Morley, D. Vaidya, F. Liu, F.L. Chen, H. Stuhlmann, G.I. Fishman, Heterogeneous expression of gap junction channels in the heart leads to conduction defects and ventricular dysfunction. Circulation 104(10), 1194\u20131199 (2001)","journal-title":"Circulation"},{"issue":"1","key":"3823_CR58","doi-asserted-by":"publisher","first-page":"117","DOI":"10.2337\/dc16-1580","volume":"40","author":"P Kumarathurai","year":"2017","unstructured":"P. Kumarathurai, C. Anholm, B.S. Larsen, R.H. Olsen, S. Madsbad, O. Kristiansen, O.W. Nielsen, S.B. Haugaard, A. Sajadieh, Effects of liraglutide on heart rate and heart rate variability: a randomized, double-blind, placebo-controlled crossover study. Diabetes Care 40(1), 117\u2013124 (2017). https:\/\/doi.org\/10.2337\/dc16-1580","journal-title":"Diabetes Care"},{"key":"3823_CR59","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.exger.2013.12.016","volume":"51","author":"YN Guo","year":"2014","unstructured":"Y.N. Guo, J.C. Wang, G.Y. Cai, X. Hu, S.Y. Cui, Y. Lv, Z. Yin, B. Fu, Q. Hong, X.M. Chen, AMPK-mediated downregulation of connexin43 and premature senescence of mesangial cells under high-glucose conditions. Exp. Gerontol. 51, 71\u201381 (2014). https:\/\/doi.org\/10.1016\/j.exger.2013.12.016","journal-title":"Exp. Gerontol."},{"issue":"1","key":"3823_CR60","doi-asserted-by":"publisher","first-page":"66","DOI":"10.14336\/ad.2017.0426","volume":"9","author":"X Li","year":"2018","unstructured":"X. Li, L. Yu, J. Gao, X. Bi, J. Zhang, S. Xu, M. Wang, M. Chen, F. Qiu, G. Fu, Apelin ameliorates high glucose-induced downregulation of connexin 43 via ampk-dependent pathway in neonatal rat cardiomyocytes. Aging Dis. 9(1), 66\u201376 (2018). https:\/\/doi.org\/10.14336\/ad.2017.0426","journal-title":"Aging Dis."},{"key":"3823_CR61","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2021.114674","volume":"192","author":"CC Lee","year":"2021","unstructured":"C.C. Lee, W.T. Chen, S.Y. Chen, T.M. Lee, Dapagliflozin attenuates arrhythmic vulnerabilities by regulating connexin43 expression via the AMPK pathway in post-infarcted rat hearts. Biochem. Pharmacol. 192, 114674 (2021). https:\/\/doi.org\/10.1016\/j.bcp.2021.114674","journal-title":"Biochem. Pharmacol."}],"container-title":["Endocrine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-024-03823-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12020-024-03823-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-024-03823-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,26]],"date-time":"2024-06-26T07:30:36Z","timestamp":1719387036000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12020-024-03823-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,22]]},"references-count":61,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2024,6]]}},"alternative-id":["3823"],"URL":"https:\/\/doi.org\/10.1007\/s12020-024-03823-2","relation":{},"ISSN":["1559-0100"],"issn-type":[{"value":"1559-0100","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,4,22]]},"assertion":[{"value":"24 January 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 April 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 April 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All animals\u2019 procedures were in compliance with the Guide for the Care and Use of Laboratory Animals published by the National Institutes of Health and approved by the Animal Care and Use Committee of Shanghai Sixth People\u2019s Hospital Affiliated to Shanghai Jiao Tong University School of Medicine (approval number DWLL2024-0005).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}